Conjunctivitis in dupilumab clinical trials

• Results Overview

  Patients taking dupilumab for atopic dermatitis had a higher chance of developing eye inflammation (conjunctivitis) compared to placebo, particularly if they had severe AD or previous eye problems, but this side effect was rare in patients taking the drug for other conditions.

• Study Summary

  Num Participants:

  5,612

  Study Type:

  Review

  Control Group:

  Placebo

  Efficacy End Points Treatment:

  None

  Efficacy End Points Control:

  None

  Side Effects Treatment:

  Adverse Event	Severity	Percentage Affected
  Conjunctivitis	Low

  Side Effects Control:

  Adverse Event	Severity	Percentage Affected
  Conjunctivitis	Low